Home/ Supplements/ Dandelion/ #3 - GB-LIV

#3 - GB-LIV

product on market Tablet or Pill Nutri-West Herbals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains ingredients like dandelion and yellow dock, which are traditionally used to support liver and gallbladder function. Research evidence for these specific botanical combinations is limited, though individual components show moderate potential for diuretic and digestive support. The profile maintains a high safety rating for general use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for #3 - GB-LIV
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Botanical
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Bayberry
75 mg
Red Beet
75 mg
Yellow Dock
75 mg
35 mg
Market median: 300.0mg (159 products)
Fennel
35 mg
35 mg
Market median: 60.0mg (107 products) 1 studies — no high-quality reviews
35 mg
Market median: 250.0mg (337 products) 127 studies (A:1, B:41)
Wild Yam
35 mg
Blessed Thistle
35 mg
30 mg
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)

Other Ingredients

In a special base of the following:
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions for use: One tablet daily, or as directed

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

TAMPER RESISTANT OUTER SEAL - DO NOT USE IF BROKEN.

Formulation Notes

Contains no added, starches, salt, sugar wheat, corn, yeast, soy, milk, or preservatives.

Additional Information

0931 MFG07/2010

FOR DISTRIBUTION BY HEALTH CARE PROFESSIONALS ONLY

Store in a cool, dry place.

Manufactured under strict GMP and USP guidelines.

Product # 1703-T

Metadata

Product Details

DSLD Entry Date2013-11-25
Product TypeBotanical
FormTablet or Pill
DSLD ID27495
Data Updated2026-04-11
Research

Research Evidence

5
Research Sources
29
Avg Quality
5
Other
D Taraxacum officinale extract shows antitumor effects on pediatric cancer cells and enhance mistletoe therapy
Other Complementary therapies in medicine 2018 PubMed DOI
D Taraxacum mongolicum Hand.-Mazz. extract disrupts the interaction between triple-negative breast cancer cells and tumor-associated macrophages by inhibiting RAC2/NF-κB p65/p38 MAPK pathway
Other Journal of ethnopharmacology 2025 PubMed DOI
D Revealing the metabolic mechanism of dandelion extract against A549 cells using UPLC-QTOF MS
Other Biomedical chromatography : BMC 2022 PubMed DOI
D Combined dandelion extract and all-trans retinoic acid induces cytotoxicity in human breast cancer cells
Other Scientific reports 2023 PubMed DOI
D Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways
Other Oncotarget 2016 PubMed DOI
View all evidence for Dandelion →
Compare

Similar Products

View all Dandelion products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.